- Home
- RDNT vs RNA Comparison
RDNT vs RNA Comparison
Compare RDNT & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDNT
- RNA
- Stock Information
- Founded
- RDNT 1985
- RNA 2012
- Country
- RDNT United States
- RNA United States
- Employees
- RDNT N/A
- RNA N/A
- Industry
- RDNT Medical Specialities
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- RDNT Health Care
- RNA Health Care
- Exchange
- RDNT Nasdaq
- RNA Nasdaq
- Market Cap
- RDNT 4.2B
- RNA 4.0B
- IPO Year
- RDNT 1986
- RNA 2020
- Fundamental
- Price
- RDNT $57.41
- RNA $36.27
- Analyst Decision
- RDNT Strong Buy
- RNA Strong Buy
- Analyst Count
- RDNT 5
- RNA 14
- Target Price
- RDNT $69.60
- RNA $67.71
- AVG Volume (30 Days)
- RDNT 675.7K
- RNA 2.4M
- Earning Date
- RDNT 08-10-2025
- RNA 08-08-2025
- Dividend Yield
- RDNT N/A
- RNA N/A
- EPS Growth
- RDNT N/A
- RNA N/A
- EPS
- RDNT N/A
- RNA N/A
- Revenue
- RDNT $1,869,356,000.00
- RNA $8,927,000.00
- Revenue This Year
- RDNT $9.36
- RNA N/A
- Revenue Next Year
- RDNT $8.35
- RNA $196.18
- P/E Ratio
- RDNT N/A
- RNA N/A
- Revenue Growth
- RDNT 12.76
- RNA N/A
- 52 Week Low
- RDNT $45.00
- RNA $21.51
- 52 Week High
- RDNT $93.65
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- RDNT 51.66
- RNA 67.36
- Support Level
- RDNT $55.99
- RNA $33.02
- Resistance Level
- RDNT $58.92
- RNA $34.51
- Average True Range (ATR)
- RDNT 2.13
- RNA 2.00
- MACD
- RDNT 0.05
- RNA 0.39
- Stochastic Oscillator
- RDNT 50.19
- RNA 84.94
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.